Koyfin Home > Directory > Health Care > Amicus Therapeutics > Cost of Goods Sold

Amicus Therapeutics Cost of Goods Sold Chart (FOLD)

Amicus Therapeutics annual/quarterly Cost of Goods Sold from 2006 to 2018.
  • Amicus Therapeutics Cost of Goods Sold for the quarter ending December 12, 2018 was $4m a 39.80% increase of 2m year over year
  • Amicus Therapeutics Cost of Goods Sold for the last 12 months ending December 12, 2018 was $14m a 43.93% increase of 6m year over year
  • Amicus Therapeutics Annual Cost of Goods Sold for 2018 was $14m a 56.71% increase of 8m from 2017
  • Amicus Therapeutics Annual Cost of Goods Sold for 2017 was $6m a 86.64% increase of 5m from 2016
  • Amicus Therapeutics Annual Cost of Goods Sold for 2016 was $1m a -1,519.69% decrease of -13m from 2015
Other Income Statement Metrics:
  • Amicus Therapeutics EBITDA for the quarter ending December 12, 2018 was $-68m a 20.09% decrease of -14m year over year
  • Amicus Therapeutics Net Income for the quarter ending December 12, 2018 was $-78m a 36.07% decrease of -28m year over year
  • Amicus Therapeutics Total Revenue for the quarter ending September 09, 2018 was $21m a 28.49% increase of 6m year over year
View Chart On Koyfin

Quarterly FOLD Cost of Goods Sold Data

12/2018$4m
09/2018$4m
06/2018$3m
03/2018$3m
12/2017$3m
09/2017$2m
06/2017$1m
03/2017$1m
12/2016$0m
09/2016$0m

Annual FOLD Cost of Goods Sold Data

2018$14m
2017$6m
2016$1m
2013$13m
2012$20m
2011$24m
2010$14m
2009$21m
2008$12m
2007$13m